Stay updated on Safety, PK, and PD of FDL169 in CF - Clinical Trial

Sign up to get notified when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety, PK, and PD of FDL169 in CF - Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now presents the study record for the FDL169 cystic fibrosis trial, including its completed Phase 1 status, participant criteria, study locations, and safety and pharmacokinetic measures.
    Difference
    51%
    Check dated 2026-11-08T13:51:27.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.2 to v3.8.0, while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:14:52.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A site-wide notice announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the error page for the study record.
    Difference
    1%
    Check dated 2026-10-25T16:44:58.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T16:42:24.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T16:48:05.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the detailed study record content with a generic error screen. Only the header, footer, and minimal navigation remain, and core study information is no longer accessible.
    Difference
    18%
    Check dated 2026-09-20T20:12:55.000Z thumbnail image

Stay in the know with updates to Safety, PK, and PD of FDL169 in CF - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety, PK, and PD of FDL169 in CF - Clinical Trial page.